Heparin cofactor II-dependent antithrombin activity of calcium spirulan

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 5, 1996, Pages 554-560

  Hayakawa, Y ^a   Hayashi, T ^a,b   Hayashi, K ^a   Ozawa, T ^a   Niiya, K ^a   Sakuragawa, N ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Antithrombin activity; Calcium spirulan; Glycosidases; Heparin cofactor II; Spirulina platensis; Sulfated polysaccharide

Indexed keywords

CALCIUM SPIRULAN; DERMATAN SULFATE; HEPARIN; HEPARIN COFACTOR II; UNCLASSIFIED DRUG;

ARTICLE; FIBRINOLYSIS; PRIORITY JOURNAL;

EID: 0029816394     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199607000-00007     Document Type: Article

References (32)

1. Carrell RW, Boswell DR. Serpins the superfamily of plasma serine proteinase inhibitors. In: Barrett AJ, Salvesen G, eds. Proteinase Inhibitors. Amsterdam: Elsevier, 1986: 403-420.
2. Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505.
3. Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II: purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem 1982; 257: 2162-2169.
4. Lindahl U, Bäckström G, Thnberg L, Leder IG. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Acad Sci USA 1980; 77: 6551-6555.
5. Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716.
6. Church FC, Treanor RE, Sherrill GB, Whinna HC. Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II. Biochem Biophys Res Commun 1987; 148: 362-368.
7. Church FC, Pratt CW, Treanor RE, Whinna HC. Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor II. FEBS Lett 1988; 237: 26-30.
8. Church FC, Meade JB, Treanor RK, Whinna HC. Antithrombin activity of fucoidan: the interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem 1989; 264: 3618-3623.
9. Nishino T, Aizu Y, Nagumo T. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome. Thromb Res 1991; 62: 765-773.
10. Uehara T, Takeshita M, Maeda M. Studies on anticoagulant-active arabinan sulfates from the green alga, Codium latum. Carbohydrate Res 1992; 235: 309-311.
11. Suzuki N, Kitazato K, Takamatsu J, Saito H. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosammoglycan extracted from Stichopus japonicus Selenka. Thromb Haemost 1991; 65: 369-373.
12. Kato T, Takemoto K, Katayama H, Kuwahara Y. Effects of spirulina (Spirulina platensis) on dietary hypercholesterolemia in rats. Jap Nutr Food Assoc J 1984; 37: 323-332.
13. Nakaya N, Honma Y, Goto Y. Cholesterol lowering effect of spirulina. Nutr Rep Int 1988; 37: 1329-1337.
14. Iwata K, Munakata K, Inayama T, Kato T. Effects of Spirulina platensis on blood pressure in rats. Kagawa Nutr College Kiyo 1990; 21: 63-73.
15. Santillan C. Mass production of spirulina. Experientia 1982; 38: 40-43.
16. Hayashi K, Hayashi T, Morita N, Kojima I. An extract from Spirulina platensis is a selective inhibitor of herpes simplex virus type 1 penetration into HeLa cells. Phytotherapy Res 1993; 7: 76-80.
17. Hayashi T, Hayashi K, Maeda M, Kojima I. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996; 59: 83-87.
18. Hayakawa Y, Hayashi T, Hayashi T, Niiya K, Sakuragawa N. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps. Blood Coag Fibrinol 1995; 6: 643-649.
19. Yamagishi R, Niwa M, Kondo S-I, Sakuragawa N, Koide T. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Thromb Res 1984; 36: 633-642.
20. Jaffe EA, Armellino D, Tollefsen DM. Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochem Biophys Res Commun 1985; 132: 368-374.
21. Yamagishi R, Niwa M, Sakuragawa N. Thrombin inhibitory activity of heparin cofactor II depends on the molecular weight and sulfate amount of dextran sulfate. Thromb Res 1986; 44: 347-354.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
23. Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM. Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochem 1988; 27: 752-759.
24. Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 1987; 154: 367-382.
25. Whinna HC, Blinder MA, Szewczyk M, Tollefsen DM, Church FC. Role of lysine 173 in heparin binding to heparin cofactor II. J Biol Chem 1991; 266: 8129-8135.
26. Oslo: mutation of Arg-189 to His decreases the affinity for dermatan sulfate. J Biol Chem 1989; 264: 5128-5133.
27. Blinder MA, Tollefsen DM. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II. J Biol Chem 1990; 265: 286-291.
28. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
29. Sheehan JP, Tollefsen DM, Sadler JH. Heparin cofactor II is regulated allostencally and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. J Biol Chem 1994; 269: 32747-32751.
30. Björk I, Danielsson Å. Antithrombin and related inhibitors of coagulation proteinases. In: Barrett AJ, Salvesen G, eds. Proteinase Inhibitors. Amsterdam: Elsevier, 1986: 489-513.
31. Sie P, Petitou M, Lormeau JC, Dupouy D, Boneu B, Choay J. Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II. Biochim Biophys Acta 1988; 966: 188-195.
32. Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA. Increased sulfation improves the anti-coagulant activities of heparan sulfate and dermatan sulfate. Biochem J 1987; 248: 889-896.